|
US5077044A
(en)
*
|
1980-05-19 |
1991-12-31 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Novel non-reverting shigella live vaccines
|
|
US5174993A
(en)
*
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US4722848A
(en)
*
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US5110587A
(en)
*
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
|
US5338683A
(en)
*
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
|
US4510245A
(en)
*
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
ZA858044B
(en)
*
|
1984-11-01 |
1987-05-27 |
American Home Prod |
Oral vaccines
|
|
US5643579A
(en)
*
|
1984-11-01 |
1997-07-01 |
American Home Products Corporation |
Oral vaccines
|
|
US5036006A
(en)
*
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4945050A
(en)
*
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4797368A
(en)
*
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
GB8508845D0
(en)
*
|
1985-04-04 |
1985-05-09 |
Hoffmann La Roche |
Vaccinia dna
|
|
US5223424A
(en)
*
|
1985-09-06 |
1993-06-29 |
Prutech Research And Development |
Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
|
|
US4790987A
(en)
*
|
1985-11-15 |
1988-12-13 |
Research Corporation |
Viral glycoprotein subunit vaccine
|
|
US5310668A
(en)
*
|
1986-06-20 |
1994-05-10 |
Merck & Co., Inc. |
Varicella-zoster virus as a live recombinant vaccine
|
|
US5242829A
(en)
*
|
1986-09-23 |
1993-09-07 |
Therion Biologics Corporation |
Recombinant pseudorabies virus
|
|
US5387744A
(en)
*
|
1987-06-04 |
1995-02-07 |
Washington University |
Avirulent microbes and uses therefor: Salmonella typhi
|
|
US5294441A
(en)
*
|
1987-06-04 |
1994-03-15 |
Washington University |
Avirulent microbes and uses therefor: salmonella typhi
|
|
IL86583A0
(en)
*
|
1987-06-04 |
1988-11-15 |
Molecular Eng Ass |
Vaccine containing a derivative of a microbe and method for the production thereof
|
|
US5112749A
(en)
*
|
1987-10-02 |
1992-05-12 |
Praxis Biologics, Inc. |
Vaccines for the malaria circumsporozoite protein
|
|
CH682669A5
(fr)
*
|
1989-03-08 |
1993-10-29 |
Health Research Inc |
Virus recombinant modifié pour exprimer un produit de gènes chez un hôte, procédés et vaccin correspondants.
|
|
US5225336A
(en)
*
|
1989-03-08 |
1993-07-06 |
Health Research Incorporated |
Recombinant poxvirus host range selection system
|
|
US5703055A
(en)
*
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5591439A
(en)
*
|
1989-03-24 |
1997-01-07 |
The Wistar Institute Of Anatomy And Biology |
Recombinant cytomegalovirus vaccine
|
|
JP3004049B2
(ja)
*
|
1989-03-31 |
2000-01-31 |
ワシントン ユニバーシティー |
病原性のないｐｈｏＰ型微生物を含有するワクチン
|
|
DE69016956T2
(de)
*
|
1989-12-04 |
1995-07-20 |
Akzo Nobel Nv |
Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
|
|
US5294548A
(en)
*
|
1990-04-02 |
1994-03-15 |
American Biogenetic Sciences, Inc |
Recombianant Hepatitis a virus
|
|
AU7906691A
(en)
*
|
1990-05-23 |
1991-12-10 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5462734A
(en)
*
|
1990-11-02 |
1995-10-31 |
Wisconsin Alumni Research Foundation |
Bovine herpesvirus vaccine and method of using same
|
|
US5240703A
(en)
*
|
1991-03-01 |
1993-08-31 |
Syntro Corporation |
Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
|
|
US6034298A
(en)
*
|
1991-08-26 |
2000-03-07 |
Prodigene, Inc. |
Vaccines expressed in plants
|
|
US5955088A
(en)
*
|
1992-02-03 |
1999-09-21 |
Cedars-Sinai Medical Center |
Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
|
|
US5981505A
(en)
*
|
1993-01-26 |
1999-11-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
|
DE69434469T2
(de)
|
1993-01-26 |
2006-06-14 |
Univ Pennsylvania |
Zusammensetzungen und verfahren zur verabreichung von genetischem material
|
|
US5593972A
(en)
*
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
|
EP0708659A4
(en)
*
|
1993-06-07 |
2000-08-23 |
Genentech Inc |
HIV ENVELOPE POLYPEPTIDE
|
|
US5739118A
(en)
*
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US6156319A
(en)
*
|
1994-07-25 |
2000-12-05 |
The Trustees Of The University Of Pennsylvania |
Soluble herpesvirus glycoprotein complex vaccine
|
|
NL9401820A
(nl)
*
|
1994-11-02 |
1996-06-03 |
Meyn Maschf |
Inrichting voor het bewerken van aan zijn poten opgehangen gevogelte.
|
|
US5962428A
(en)
*
|
1995-03-30 |
1999-10-05 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US5650309A
(en)
*
|
1995-05-16 |
1997-07-22 |
The Regents Of The University Of California |
Viral vectors
|
|
US5698202A
(en)
*
|
1995-06-05 |
1997-12-16 |
The Wistar Institute Of Anatomy & Biology |
Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier
|
|
AUPN443995A0
(en)
*
|
1995-07-27 |
1995-08-17 |
Csl Limited |
Papillomavirus polyprotein
|
|
GB9717953D0
(en)
*
|
1997-08-22 |
1997-10-29 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9727262D0
(en)
*
|
1997-12-24 |
1998-02-25 |
Smithkline Beecham Biolog |
Vaccine
|
|
US20050031638A1
(en)
*
|
1997-12-24 |
2005-02-10 |
Smithkline Beecham Biologicals S.A. |
Vaccine
|
|
US6589529B1
(en)
*
|
1998-10-30 |
2003-07-08 |
Children's Hospital Medical Center |
Rotavirus subunit vaccine
|
|
US8209006B2
(en)
*
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
|
US7245963B2
(en)
*
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
|
WO2005033333A2
(en)
*
|
2003-10-07 |
2005-04-14 |
Dako Denmark A/S |
Methods and compositions for the diagnosis of cancer
|
|
JP5345053B2
(ja)
|
2006-04-19 |
2013-11-20 |
浦項工科大學校 産學協力團 |
子宮頸癌の予防及び治療のためのヒトパピローマウイルスポリペプチドと免疫増強剤を含む組成物
|
|
JP2009534331A
(ja)
|
2006-04-21 |
2009-09-24 |
トランジェーヌ、ソシエテ、アノニム |
Ｈｐｖ‐１８を主体とするパピローマウイルスワクチン
|
|
CN101679475B
(zh)
|
2006-07-28 |
2015-08-12 |
宾夕法尼亚大学托管会 |
改进的疫苗及其使用方法
|
|
KR20140137679A
(ko)
|
2013-05-23 |
2014-12-03 |
삼성전자주식회사 |
카드 소켓 장치
|